AtriCure, Inc. 4
4 · AtriCure, Inc. · Filed Mar 21, 2017
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
LUX ANDREW L
V.P. & Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2017-03-17$6.27/sh+20,000$125,400→ 85,589 total - Sale
Common Stock
2017-03-17$18.85/sh−20,000$377,000→ 65,589 total - Exercise/Conversion
Stock Option (right to buy)
2017-03-17−20,000→ 0 totalExercise: $6.27From: 2013-10-25Exp: 2022-10-25→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $18.64 to $18.99 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]These options were granted on October 25, 2012 and are exercisable as to 25% of the shares upon the one-year anniversary of the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.